Robert E. O’Neill

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

Julie Talon, Mirella Salvatore, Robert E. O’Neill et al. · Proceedings of the National Academy of Sciences · 2000 · 319 citations

Life Sciences, Immunology, Infectious Diseases +13

NS1-Binding Protein (NS1-BP): a Novel Human Protein That Interacts with the Influenza A Virus Nonstructural NS1 Protein Is Relocalized in the Nuclei of Infected Cells

Thorsten Wolff, Robert E. O’Neill, Peter Palese · Journal of Virology · 1998 · 134 citations · Full text

Life Sciences, Biology, Molecular Biology +15

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents

Timo Vesikari, Lars Østergaard, Javier Díez‐Domingo et al. · Journal of the Pediatric Infectious Diseases Society · 2015 · 59 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

Timo Vesikari, Jacek Wysocki, Johannes Beeslaar et al. · Journal of the Pediatric Infectious Diseases Society · 2016 · 42 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine

Shelly Senders, Prakash Bhuyan, Qin Jiang et al. · The Pediatric Infectious Disease Journal · 2016 · 42 citations

Veterinary Medicine, Immunology, Infectious Diseases +17